BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 37421461)

  • 1. Construction and validation of a nomogram for hepatocellular carcinoma patients based on HCC-GRIm score.
    Yu X; Yang R; He Z; Li K; Zeng P
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):12013-12024. PubMed ID: 37421461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction and validation of a nomogram for hepatocellular carcinoma patients treated by traditional Chinese medicine based on inflammation, nutrition, and blood lipid indicators.
    Yu X; Yang R; He Z; Zeng P
    J Cancer Res Clin Oncol; 2023 Sep; 149(11):8969-8979. PubMed ID: 37160627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction and validation of a machine learning-based nomogram to predict the prognosis of HBV associated hepatocellular carcinoma patients with high levels of hepatitis B surface antigen in primary local treatment: a multicenter study.
    Xiong Y; Qiao W; Wang Q; Li K; Jin R; Zhang Y
    Front Immunol; 2024; 15():1357496. PubMed ID: 38601167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of web
    Zhan G; Cao P; Peng H
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Oct; 48(10):1546-1560. PubMed ID: 38432884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Nomogram for Hepatitis B Virus-related Hepatocellular Carcinoma With Adjuvant Transarterial Chemoembolization After Radical Resection.
    Huang J; Liu FC; Li L; Yuan SX; Yang Y; Jiang BG; Liu H; Pan ZY
    Am J Clin Oncol; 2020 Jan; 43(1):20-27. PubMed ID: 31633514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. OHCCPredictor: an online risk stratification model for predicting survival duration of older patients with hepatocellular carcinoma.
    Tan J; Yu Y; Lin X; He Y; Jin W; Qian H; Li Y; Xu X; Zhao Y; Ning J; Zhang Z; Chen J; Wu X
    Hepatol Int; 2024 Apr; 18(2):550-567. PubMed ID: 37067674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The study of nomogram based on Ishak inflammation score for recurrence of hepatocellular carcinoma after curative resection].
    Luo XY; Du CY; Wei XF; Jiang N; Li M; Liao R
    Zhonghua Wai Ke Za Zhi; 2018 Feb; 56(2):124-129. PubMed ID: 29397626
    [No Abstract]   [Full Text] [Related]  

  • 8. A New Prognostic Algorithm Predicting HCC Recurrence in Patients With Barcelona Clinic Liver Cancer Stage B Who Received PA-TACE.
    Hu S; Gan W; Qiao L; Ye C; Wu D; Liao B; Yang X; Jiang X
    Front Oncol; 2021; 11():742630. PubMed ID: 34745962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel prognostic nomogram based on microvascular invasion and hematological biomarkers to predict survival outcome for hepatocellular carcinoma patients.
    Li X; Huang H; Yu X; Chen P; Ouyang J; Huang B
    Surg Oncol; 2020 Jun; 33():51-57. PubMed ID: 32561099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammation-related nomogram for predicting survival of patients with unresectable hepatocellular carcinoma received conversion therapy.
    Wu JL; Luo JY; Jiang ZB; Huang SB; Chen GR; Ran HY; Liang QY; Huang MS; Lai LS; Chen JW
    World J Gastroenterol; 2023 May; 29(20):3168-3184. PubMed ID: 37346152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multi-institutional study to predict the benefits of DEB-TACE and molecular targeted agent sequential therapy in unresectable hepatocellular carcinoma using a radiological-clinical nomogram.
    Liu K; Zheng X; Lu D; Tan Y; Hou C; Dai J; Shi W; Jiang B; Yao Y; Lu Y; Cao Q; Chen R; Zhang W; Xie J; Chen L; Jiang M; Zhang Z; Liu L; Liu J; Li J; Lv W; Wu X
    Radiol Med; 2024 Jan; 129(1):14-28. PubMed ID: 37863847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A practical nomogram and risk stratification system predicting the cancer-specific survival for patients with early hepatocellular carcinoma.
    Yan B; Su BB; Bai DS; Qian JJ; Zhang C; Jin SJ; Jiang GQ
    Cancer Med; 2021 Jan; 10(2):496-506. PubMed ID: 33280269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and Validation of a Prognostic Nomogram in AFP-negative hepatocellular carcinoma.
    Wang X; Mao M; He Z; Zhang L; Li H; Lin J; He Y; Dai S; Hu W; Liu W
    Int J Biol Sci; 2019; 15(1):221-228. PubMed ID: 30662361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening of Hepatocellular Carcinoma Patients with High Risk of Early Recurrence After Radical Hepatectomy Using a Nomogram Model Based on the γ-Glutamyl Transpeptidase-to-Albumin Ratio.
    Pang S; Shi Y; Xu D; Sun Z; Chen Y; Yang Y; Zhao X; Si-Ma H; Yang N
    J Gastrointest Surg; 2022 Aug; 26(8):1-9. PubMed ID: 35508683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic and prognostic nomograms for bone metastasis in hepatocellular carcinoma.
    Hu C; Yang J; Huang Z; Liu C; Lin Y; Tong Y; Fan Z; Chen B; Wang C; Zhao CL
    BMC Cancer; 2020 Jun; 20(1):494. PubMed ID: 32487048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A web-based nomogram model for predicting the overall survival of hepatocellular carcinoma patients with external beam radiation therapy: A population study based on SEER database and a Chinese cohort.
    Zhan G; Peng H; Zhou L; Jin L; Xie X; He Y; Wang X; Du Z; Cao P
    Front Endocrinol (Lausanne); 2023; 14():1070396. PubMed ID: 36798659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of prognostic nomograms in patients with hepatocellular carcinoma: a population-based study.
    Zang Y; Long P; Wang M; Huang S; Chen C
    Future Oncol; 2021 Dec; 17(36):5053-5066. PubMed ID: 34676798
    [No Abstract]   [Full Text] [Related]  

  • 18. Preoperative contrast-enhanced computed tomography-based radiomics model for overall survival prediction in hepatocellular carcinoma.
    Deng PZ; Zhao BG; Huang XH; Xu TF; Chen ZJ; Wei QF; Liu XY; Guo YQ; Yuan SG; Liao WJ
    World J Gastroenterol; 2022 Aug; 28(31):4376-4389. PubMed ID: 36159012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of a nomogram for survival prediction in hepatocellular carcinoma after partial hepatectomy.
    Lu Y; Ren S; Jiang J
    BMC Surg; 2023 Jan; 23(1):27. PubMed ID: 36717904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New nomogram predicts the recurrence of hepatocellular carcinoma in patients with negative preoperative serum AFP subjected to curative resection.
    Gan W; Huang JL; Zhang MX; Fu YP; Yi Y; Jing CY; Fan J; Zhou J; Qiu SJ
    J Surg Oncol; 2018 Jun; 117(7):1540-1547. PubMed ID: 29572833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.